Drawing for AFT PHARMACEUTICALS

USPTO serial 79183211

AFT PHARMACEUTICALS

Reviewed by CopyMark Law Group

Reg. 5293339Status 706Renewal
Filing date
Status date
Registration date
Sep 26, 2017
Examiner
LEIPZIG, MARC J
Law office
GENERIC WEB UPDATE

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with AFT PHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mainak H. Mehta

Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP525 B Street, Suite 2200San Diego, CA 92101United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of symptoms of cold and flu; pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, and inflammatory connective tissue diseases; pharmaceutical preparations for pain relief; [ pharmaceutical preparations, namely, antihistamines for relief of symptoms of allergies and allergic conditions; ] pharmaceutical preparations for the treatment of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, and cartilage injuries; [ pharmaceutical preparations, namely, nasal spray for treating symptoms of allergies and allergic conditions: pharmaceutical preparations, namely, ointment for treatment of scalp conditions and skin infections; pharmaceutical preparations for use in ocular disorders: pharmaceutical preparations, namely, moisturizing eye ointment, and eye drops for treatment of conjunctivitis and symptoms of allergies; pharmaceutical preparations, namely, gel for the treatment of oral conditions: ] pharmaceutical preparations, namely, dietary supplements for general health and well-being [;pharmaceutical preparations, namely, laxatives; pharmaceutical preparations, namely, lotions for the treatment of head lice; pharmaceutical preparations, namely, anti-fungal nail lacquer; and cream for the relief of pain associated with osteoarthritis ]ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 26, 2026REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Dec 18, 2025RNWLINTERNATIONAL REGISTRATION RENEWED—
Jun 6, 2025INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Mar 31, 2025INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Mar 31, 2025INPCINVALIDATION PROCESSED—
Jan 16, 2025INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 27, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 27, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Sep 27, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 27, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 16, 2024NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
May 16, 202471AGREGISTERED-SEC.71 ACCEPTED—
May 15, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 20, 2023ES71TEAS SECTION 71 RECEIVED—
Sep 26, 2022REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Aug 3, 2018INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Jul 29, 2018INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 10, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 13, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 13, 2018FIMPFINAL DISPOSITION PROCESSED—
Dec 26, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 29, 2017COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Nov 29, 2017APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 8, 2017ES7RTEAS SECTION 7 REQUEST RECEIVED—
Oct 8, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 26, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 11, 2017OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jul 26, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 26, 2017OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jul 11, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 8, 2017GPNXNOTIFICATION PROCESSED BY IB—
Jun 25, 2017FAXXFAX RECEIVED—
Jun 21, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 21, 2017OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 21, 2017NPUBNOTICE OF PUBLICATION—
Jun 5, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 24, 2017CNEAEXAMINERS AMENDMENT MAILED—
May 24, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 24, 2017XAECEXAMINER'S AMENDMENT ENTERED—
May 24, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 20, 2016CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 19, 2016CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 28, 2016ACECAMENDMENT FROM APPLICANT ENTERED—
Sep 28, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 22, 2016ALIEASSIGNED TO LIE—
Sep 14, 2016FAXXFAX RECEIVED—
May 13, 2016RFNTREFUSAL PROCESSED BY IB—
Apr 7, 2016RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 7, 2016RFRRREFUSAL PROCESSED BY MPU—
Apr 7, 2016RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 6, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 5, 2016DOCKASSIGNED TO EXAMINER—
Mar 1, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 26, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 25, 2016REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance